| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/01/2010 | US20100167270 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 07/01/2010 | US20100167269 Detection method for human pappilomavirus (HPV) and its application in cervical Cancer |
| 07/01/2010 | US20100167268 Seroconversion assays for detecting xenotropic murine leukemia virus-related virus |
| 07/01/2010 | US20100167267 Mass Spectrometric Quantitation |
| 07/01/2010 | US20100167266 Compositions and Methods for Determining Whether a Subject Would Benefit from Co-Receptor Inhibitor Therapy |
| 07/01/2010 | US20100167265 Vaccine against infectious agents having an intracellular phase, composition for the treatment and prevention of hiv infections, antibodies and method of diagnosis |
| 07/01/2010 | US20100167264 Quantitative analyte assay device and method |
| 07/01/2010 | US20100167263 Novel biosensor system based on recognition induced birefringence (rib) |
| 07/01/2010 | US20100167262 Method and reagent for the specific identification and quantification of one or more proteins in a sample using in particular inductively coupled plasma-mass spectrometry |
| 07/01/2010 | US20100166880 Method for treatment and diagnosis of glutamate dehydrogenase disorders |
| 07/01/2010 | US20100166821 Anti-Inflammatory, Radioprotective, and Longevity Enhancing Capabilities of Cerium Oxide Nanoparticles |
| 07/01/2010 | US20100166803 Eimeria vaccine for turkeys |
| 07/01/2010 | US20100166801 Sulfoglycolipid antigens, their process of preparation, and their use against tuberculosis |
| 07/01/2010 | US20100166797 Gammaretrovirus associated with cancer |
| 07/01/2010 | US20100166786 A mycobacterium tuberculosis fusion protein and uses thereof |
| 07/01/2010 | US20100166783 Method |
| 07/01/2010 | US20100166782 Clip inhibitors and methods of modulating immune function |
| 07/01/2010 | US20100166781 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity |
| 07/01/2010 | US20100166777 Hematopoietic cells that express mosc-1 |
| 07/01/2010 | US20100166771 detecting NTHi bacteria in a biological sample using a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 599; vaccines and methods of treating and preventing NTHi related disorders such as NTHi infection of the middle ear and/or the nasopharynx |
| 07/01/2010 | US20100166770 Antagonists of bacterial sequences |
| 07/01/2010 | US20100166763 Method for determining the immunogenicity of an antigen |
| 07/01/2010 | US20100166761 Compositions and methods for the treatment of immune related diseases |
| 07/01/2010 | US20100166747 Methods and compositions for treating tumor diseases |
| 07/01/2010 | US20100166737 P38Alpha as a Therapeutic Target in Bladder Carcinoma |
| 07/01/2010 | US20100166731 Methods and Compositions for Treating Cancer |
| 07/01/2010 | US20100166720 Generation of neuronal cells from pluripotent stem cells |
| 07/01/2010 | US20100166710 Compositions and Methods for Inducing Neuronal Differentiation |
| 07/01/2010 | US20100166707 Extracellular matrix/metastasis modifier genes for the prevention or inhibition of metastasis or growth of tumor and for characterization of tumor |
| 07/01/2010 | US20100166705 Culturing circular ssDNA viruses for the production of vaccines |
| 07/01/2010 | US20100166704 Methods and compositions for inhibition of viral replication |
| 07/01/2010 | US20100166694 Diagnostic markers of wound infection |
| 07/01/2010 | US20100166661 siRNA COMPOSITIONS AND METHODS FOR POTENTLY INHIBITING VIRAL INFECTION |
| 07/01/2010 | DE102009043486A1 Cosmetic use of an active agent or active agent mixture, obtained from e.g. Clintonia borealis or Punica granatum, for preventing and/or inhibiting the effect (i.e. non-pathological effect) of psychoemotional stress on the hair |
| 07/01/2010 | DE102008064553A1 Verfahren zum Nachweis und/oder zur Identifizierung hormonell wirksamer Substanzen A method for detecting and / or identifying hormonally active substances, |
| 07/01/2010 | DE102008062789A1 Evaluating the qualities of egg cells, comprises analyzing follicular fluid of the egg cells to be evaluated, and applying the analyzed results for the evaluation of the individual qualities |
| 07/01/2010 | DE102008055120A1 Präparation und Amplifikation von Nukleinsäuren mittels magnetischer Partikel Preparation and amplification of nucleic acids using magnetic particles |
| 07/01/2010 | CA2748566A1 Method for evaluation of differentiation ability of stem cell |
| 07/01/2010 | CA2748318A1 Novel biotracers and uses thereof for controlling filtration plants |
| 07/01/2010 | CA2748267A1 Large scale pancreatic islet purification |
| 07/01/2010 | CA2748265A1 Monochrome multiplex quantitative pcr |
| 07/01/2010 | CA2748224A1 Methods and means for typing a sample comprising colorectal cancer cells |
| 07/01/2010 | CA2748117A1 Method for detection of xmrv |
| 07/01/2010 | CA2748030A1 Methods and genotyping panels for detecting alleles, genomes, and transcriptomes |
| 07/01/2010 | CA2748011A1 Expression vector for producing protein derived from foreign gene in large quantity using animal cells, and use thereof |
| 07/01/2010 | CA2747836A1 Method for verifying and/or identifying hormonally effective substances |
| 07/01/2010 | CA2747760A1 Biomarker |
| 07/01/2010 | CA2746942A1 Ex-vivo passive protection bacteremia assay |
| 07/01/2010 | CA2746716A1 Method for detecting a target nucleic acid in a sample |
| 07/01/2010 | CA2746452A1 Methods of detection of changes in cells |
| 07/01/2010 | CA2745371A1 Methods, reagents and kits for the identification of modulators of voltage-gated sodium channels |
| 07/01/2010 | CA2745189A1 Methods for detection of sepsis |
| 07/01/2010 | CA2743444A1 Diagnostic system for selecting nutrition and pharmacological products for animals |
| 06/30/2010 | EP2202660A1 System and method for consensus-calling with per-base quality values for sample assemblies |
| 06/30/2010 | EP2202520A1 Clinically intelligent diagnostic devices and methods |
| 06/30/2010 | EP2202511A2 Quantitative analyzing method and quantitative analyzer using sensor |
| 06/30/2010 | EP2202322A1 Methods for producing a paired tag from a nucleic acid sequence and methods of use thereof |
| 06/30/2010 | EP2202321A1 Evaluation of the potential risk of drug induced mood disturbance and suicide:use of a dedicated platform |
| 06/30/2010 | EP2202320A1 Methods and means for typing a sample comprising colorectal cancer cells |
| 06/30/2010 | EP2202319A1 Nucleic acid probe, and method for production of probe polymer |
| 06/30/2010 | EP2202312A2 DNA polymerases having improved labelled nucleotide incorporation properties |
| 06/30/2010 | EP2202308A2 Methods and compositions for polypeptide engineering |
| 06/30/2010 | EP2202305A1 Primer for amplification of rrna of bacterium belonging to the genus legionella, detection method, and detection kit |
| 06/30/2010 | EP2202304A1 Modified creatinine amidohydrolase |
| 06/30/2010 | EP2202303A1 Novel glucose dehydrogenase |
| 06/30/2010 | EP2202241A2 Therapeutic compounds and methods for modulating V3, a versican isoform |
| 06/30/2010 | EP2202238A1 Nucleotide Compounds including a rigid linker |
| 06/30/2010 | EP2201363A2 Detection of saliva proteins modulated secondary to ductal carcinoma in situ of the breast |
| 06/30/2010 | EP2201143A2 Tools and methods for genetic tests using next generation sequencing |
| 06/30/2010 | EP2201141A1 Prognostic molecular markers for et-743 treatment |
| 06/30/2010 | EP2201140A2 Preventive/remedy for cancer |
| 06/30/2010 | EP2201139A1 Detection of germs associated with periodontitis |
| 06/30/2010 | EP2201138A1 Grading, staging, and prognosing cancer using osteopontin-c |
| 06/30/2010 | EP2201137A1 Measurement of arylesterase enzymatic activity and assessment of genetic polymorphisms located in the pon1 gene as a diagnostic tool in autism-spectrum disorders |
| 06/30/2010 | EP2201135A2 Individualized cancer treatments |
| 06/30/2010 | EP2201134A2 Gene expression signatures in enriched tumor cell samples |
| 06/30/2010 | EP2201133A1 Methods of using genetic markers and related epistatic interactions |
| 06/30/2010 | EP2201132A2 Marker sequences for multiple sclerosis and use thereof |
| 06/30/2010 | EP2201130A1 Sensitive and rapid methods of using chimeric receptors to identify autoimmune disease |
| 06/30/2010 | EP2201129A1 Generic kinase/phosphatase assay with single readout |
| 06/30/2010 | EP2201128A1 Polymerized conjugates for biological applications |
| 06/30/2010 | EP2201119A2 Advanced cervical cell screening methods |
| 06/30/2010 | EP2201118A2 Compositions and methods for the identification of inhibitors of retroviral infection |
| 06/30/2010 | EP2201108A1 Enzyme blends for fermentation |
| 06/30/2010 | EP2201094A1 Hydrogel labeled primer extension method for microarrays |
| 06/30/2010 | EP2201037A1 The present invention relates to methods for prediction of the therapeutic success of breast cancer therapy |
| 06/30/2010 | EP2201009A2 Monomethine dyes |
| 06/30/2010 | EP2200648A1 Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects |
| 06/30/2010 | EP2200620A1 Infectious disease testing of menstrual fluid, endometrial /menstrual cells, amniotic fluid, umbilical cord blood or other samples |
| 06/30/2010 | EP2200562A2 Dental composition for detecting bacteria, kit of parts and use thereof |
| 06/30/2010 | EP1957670B1 Homogeneous luminescence bioassay |
| 06/30/2010 | EP1819833B1 Genetic variant of the annexin a5 gene |
| 06/30/2010 | EP1812583B1 Scoring method for determining pancreas suitability for islet isolation |
| 06/30/2010 | EP1721985B1 Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-length virus genome replicative cell having the nucleic acid construct transferred thereinto and method of constructing hepatitis c viral particles |
| 06/30/2010 | EP1531180B1 Method of diagnosing risk of myocardial infarction |
| 06/30/2010 | EP1496359B1 Substrates for hybridization and method of using the same |
| 06/30/2010 | EP1390535B1 Combinatorial libraries of monomer domains |
| 06/30/2010 | EP1379625B1 Cd4+cd25+ regulatory t cells from human blood |
| 06/30/2010 | EP1332366B1 Methods for the Assessment of Cellular Proliferative Disorders |
| 06/30/2010 | CN1869704B Method for quickly determining host protein interaction with pathogenic bacteria |